Zobrazeno 1 - 10
of 238
pro vyhledávání: '"Anne Marie Stoppa"'
Autor:
Laurent Garderet, Eric Beohou, Denis Caillot, Anne Marie Stoppa, Cyrille Touzeau, Marie Lorraine Chretien, Lionel Karlin, Philippe Moreau, Jean Fontan, Didier Blaise, Emmanuelle Polge, Mor Seny Gueye, Souhila Ikhlef, Zora Marjanovic, Myriam Labopin, Mohamad Mohty
Publikováno v:
Haematologica, Vol 101, Iss 11 (2016)
The feasibility and efficacy of high-dose melphalan followed by autologous hematopoietic stem cell transplantation in newly diagnosed elderly patients with multiple myeloma was analyzed prospectively. Fifty-six multiple myeloma patients, aged 65 year
Externí odkaz:
https://doaj.org/article/2e2b6ca952034eef8972c38880ce31d0
Autor:
Anaïs Schavgoulidze, Alexis Talbot, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Salomon Manier, Laure Buisson, Sabrina Mahéo, Laura Do Souto Ferreira, Luka Pavageau, Cyrille Hulin, Jean-Pierre Marolleau, Laurent Voillat, Karim Belhadj, Marion Divoux, Borhane Slama, Sabine Brechignac, Margaret Macro, Anne-Marie Stoppa, Laurence Sanhes, Frédérique Orsini-Piocelle, Jean Fontan, Marie-Lorraine Chretien, Hélène Demarquette, Mohamad Mohty, Hervé Avet-Loiseau, Jill Corre
Publikováno v:
Blood. 141:1308-1315
Cytogenetic abnormalities (CAs) are known to be the preponderant prognostic factor in multiple myeloma. Our team has recently developed a prognostic score based on 6 CAs, with which del(1p32) appears to be the second worst abnormality after del(17p).
Autor:
Anais Schavgoulidze, Valerie Lauwers-Cances, Aurore Perrot, Titouan Cazaubiel, Marie-Lorraine Chretien, Philippe Moreau, Thierry Facon, Xavier Leleu, Lionel Karlin, Anne-Marie Stoppa, Olivier Decaux, Karim Belhadj, Bertrand Arnulf, Mohamad Mohty, Clara M Ariette, Cecile Fohrer-Sonntag, Pascal Lenain, Jean-Pierre Marolleau, Mourad Tiab, Carla Araujo, Frederique Orsini-Piocelle, Arnaud Jaccard, Murielle Roussel, Lotfi Benboubker, Jean-Richard Eveillard, Mamoun Dib, Marion Divoux, Michel Attal, Herve Avet-Loiseau, Jill Corre
Publikováno v:
Haematologica
Haematologica, 2023, 108 (5), pp.1374. ⟨10.3324/haematol.2021.280566⟩
Haematologica, 2023, 108 (5), pp.1374. ⟨10.3324/haematol.2021.280566⟩
In the era of personalized treatment in multiple myeloma, high-risk patients must be accurately identified. The International Myeloma Working Group recommends using the Revised International Staging System (R-ISS) to pick out high-risk patients. The
Autor:
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Neil K. Rabin, Anne Marie Stoppa, Ellen Meijer, Jean-Baptiste Mear, Sacha Zeerleder, Jiri Mayer, Roland Fenk, Nathalie Fegueux, Patrice Chevallier, Eva Konirova, John A. Snowden, Monika Engelhardt, Kim Orchard, Cyrille Hulin, Nicolaas Schaap, Claudia Sossa, Ahmet Elmaagacli, Donal P. McLornan, Patrick J. Hayden, Stefan Schönland, Ibrahim Yakoub-Agha
Publikováno v:
Bone Marrow Transplantation. Nature Publishing Group
Beksac, M, Iacobelli, S, Koster, L, Cornelissen, J, Griskevicius, L, Rabin, N K, Stoppa, A M, Meijer, E, Mear, J-B, Zeerleder, S, Mayer, J, Fenk, R, Fegueux, N, Chevallier, P, Konirova, E, Snowden, J A, Engelhardt, M, Orchard, K, Hulin, C, Schaap, N, Sossa, C, Elmaagacli, A, McLornan, D P, Hayden, P J, Schönland, S & Yakoub-Agha, I 2023, ' An early post-transplant relapse prediction score in multiple myeloma : a large cohort study from the chronic malignancies working party of EBMT ', Bone Marrow Transplantation . https://doi.org/10.1038/s41409-023-01999-1
Beksac, M, Iacobelli, S, Koster, L, Cornelissen, J, Griskevicius, L, Rabin, N K, Stoppa, A M, Meijer, E, Mear, J-B, Zeerleder, S, Mayer, J, Fenk, R, Fegueux, N, Chevallier, P, Konirova, E, Snowden, J A, Engelhardt, M, Orchard, K, Hulin, C, Schaap, N, Sossa, C, Elmaagacli, A, McLornan, D P, Hayden, P J, Schönland, S & Yakoub-Agha, I 2023, ' An early post-transplant relapse prediction score in multiple myeloma : a large cohort study from the chronic malignancies working party of EBMT ', Bone Marrow Transplantation . https://doi.org/10.1038/s41409-023-01999-1
Early relapse (ER) following Autologous Hematopoietic Cell Transplantation (AHCT) confers a poor prognosis. We therefore developed a novel scoring system to predict ER. A total of 14,367 AHCT-1 patients were transplanted between 2014 and 2019, and we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43fb4c1e1c34a89ee68a56aa14fdcf34
https://pure.eur.nl/en/publications/a0b2dfef-0ebe-45fa-8fa3-a0858599ba8f
https://pure.eur.nl/en/publications/a0b2dfef-0ebe-45fa-8fa3-a0858599ba8f
Autor:
Nico Gagelmann, Dirk‐Jan Eikema, Linda Koster, Tanja Netelenbos, Andrew McDonald, Anne‐Marie Stoppa, Roland Fenk, Achilles Anagnostopoulos, Gwendolyn van Gorkom, Eric Deconinck, Claude‐Eric Bulabois, Michel Delforge, Donald Bunjes, William Arcese, Péter Reményi, Maija Itälä‐Remes, Lorenz Thurner, Ali Zahit Bolaman, Yafour Nabil, Johan Lund, Hélène Labussière‐Wallet, Patrick J. Hayden, Meral Beksac, Stefan Schönland, Ibrahim Yakoub‐Agha
Publikováno v:
European Journal of Haematology.
Background: No adequate data exist on the impact of multiple myeloma (MM) with extramedullary disease (EMD) after autograft and maintenance therapy.Methods: We identified 808 patients with newly diagnosed MM who received first autograft, of whom 107
Autor:
Alexis Talbot, Arthur Bobin, Léa Tabone, Jérôme Lambert, Catherine Boccaccio, Cécile Deal, Marie-Odile Petillon, Olivier Allangba, Philippe Agape, Pierre Arnautou, Rakiba Belkhir, Sylvie Cailleres, Driss Chaoui, Marie-Lorraine Chrétien, Olivier Decaux, Samantha Schulmann, Laurent Frenzel, Lauris Gastaud, Antoine Huart, Cyrille Hulin, Lionel Karlin, Kamel Laribi, Ronan Le Calloch, Pascal Lenain, Margaret Macro, Salomon Manier, Lydia Montes, Stéphane Moreau, Philippe Moreau, Véronique Morel, James Norwood, Frédérique Orsini Piocelle, Aurore Perrot, Gian Matteo Pica, Philippe Rey, Anna Schmitt, Anne-Marie Stoppa, Mourad Tiab, Cyrille Touzeau, Valérie Vidal, Marguerite Vignon, Laure Vincent, Zoé Van De Wyngaert, Charles Zarnitsky, Naima Kerbouche, Prani Paka, Xavier Leleu, Bertrand Arnulf, Hervé Avet-Loiseau, IFM: Intergroupe Francophone Du Myélome
Publikováno v:
Haematologica.
Belantamab mafodotin (BM) is an anti-BCMA antibody-drug conjugate (GSK2857916) that represents an alternative option in multiple myeloma. We sought to assess the efficacy and safety in real-world of BM in patients who benefited from an early access p
Autor:
Laurent Garderet, Frederique Kuhnowski, Benoit Berge, Murielle Roussel, Laure Devlamynck, Marie Odile Petillon, Martine Escoffre‐Barbe, Ingrid Lafon, Thierry Facon, Xavier Leleu, Lionel Karlin, Aurore Perrot, Anne‐Marie Stoppa, Bruno Royer, Carine Chaleteix, Mourad Tiab, Carla Araujo, Pascal Lenain, Margaret Macro, Karim Belhadj, Souhila Ikhlef, Cyrille Hulin, Herve Avet Loiseau, Michel Attal, Philippe Moreau
Publikováno v:
British Journal of Haematology.
Autor:
Benoit Ferment, Jérôme Lambert, Denis Caillot, Ingrid Lafon, Lionel Karlin, Anne Lazareth, Cyrille Touzeau, Xavier Leleu, Niels Moya, Stephanie Harel, Aurore Perrot, Pierre Bories, Laure Vincent, Sylvain Lamure, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Anne-Marie Stoppa, Gabriel Brisou, Olivier Decaux, Roch Houot, Steven Le Gouill, Thierry Facon, Hervé Avet-Loiseau, Philippe Moreau, Bertrand Arnulf
Publikováno v:
Blood. 140:4668-4670
Autor:
Laure Vincent, Anne Charvet-Rumpler, Lotfi Benboubker, Claire Calmettes, Anne-Marie Stoppa, Kamel Laribi, Lauriane Clement Filliatre, Fressia Honeyman, Richez Valentine, Cyrille Hulin, Frédéric Maloisel, Margaret Macro, Lionel Karlin, Vanessa Barué, Christos Chouaid, Hacène Zerazhi, Xavier Leleu
Publikováno v:
Blood. 140:4312-4314
Autor:
Murielle Roussel, Valérie Lauwers-Cances, Margaret Macro, Xavier Leleu, Bruno Royer, Cyrille Hulin, Lionel Karlin, Aurore Perrot, Cyrille Touzeau, Marie-Lorraine Chrétien, Sophie Rigaudeau, Mamoun Dib, Emmanuelle Nicolas-Virelizier, Martine Escoffre-Barbe, Karim Belhadj, Clara Mariette, Anne-Marie Stoppa, Carla Araujo, Chantal Doyen, Jean Fontan, Brigitte Kolb, Laurent Garderet, Sabine Brechignac, Jean-Valère Malfuson, Arnaud Jaccard, Pascal Lenain, Cécile Borel, Benjamin Hebraud, Omar Benbrahim, Véronique Dorvaux, Salomon Manier, Karine Augeul-Meunier, Marie-Christiane Vekemans, Edouard Randriamalala, Driss Chaoui, Jo Caers, Carine Chaleteix, Lofti Benboubker, Laure Vincent, Sylvie Glaisner, Patricia Zunic, Borhane Slama, Jean-Richard Eveillard, Catherine Humbrecht-Kraut, Véronique Morel, Philippe Mineur, Jean-Claude Eisenmann, Hélène Demarquette, Valentine Richez, Marguerite Vignon, Denis Caillot, Thierry Facon, Philippe Moreau, Anne-Laurène Colin, Pascale Olivier, Soraya Wuilleme, Hervé Avet-Loiseau, Jill Corre, Michel Attal
Publikováno v:
Blood, Vol. 139, no. 18, p. 2747-2757 (2022)
High-dose melphalan (HDM) and transplantation are recommended for eligible patients with multiple myeloma. No other conditioning regimen has proven to be more effective and/or safer. We previously reported in a phase 2 study that bortezomib can safel